Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| JC Virus | 19 | 2021 | 23 | 2.360 |
Why?
|
| Virus Internalization | 8 | 2020 | 89 | 1.240 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 9 | 2021 | 18 | 0.820 |
Why?
|
| Neuroglia | 9 | 2021 | 79 | 0.810 |
Why?
|
| Capsid Proteins | 7 | 2016 | 101 | 0.800 |
Why?
|
| Receptors, Virus | 9 | 2020 | 73 | 0.790 |
Why?
|
| Mesothelioma | 2 | 2010 | 28 | 0.670 |
Why?
|
| Simian virus 40 | 4 | 2016 | 17 | 0.610 |
Why?
|
| Polyomavirus Infections | 4 | 2020 | 45 | 0.580 |
Why?
|
| Polyomavirus | 3 | 2020 | 24 | 0.530 |
Why?
|
| N-Acetylneuraminic Acid | 3 | 2010 | 48 | 0.470 |
Why?
|
| Antiviral Agents | 3 | 2013 | 322 | 0.460 |
Why?
|
| MicroRNAs | 2 | 2010 | 692 | 0.420 |
Why?
|
| Virology | 1 | 2013 | 15 | 0.410 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 98 | 0.400 |
Why?
|
| Cell Line | 15 | 2021 | 2041 | 0.390 |
Why?
|
| Capsid | 3 | 2024 | 95 | 0.360 |
Why?
|
| Choroid Plexus | 3 | 2021 | 16 | 0.350 |
Why?
|
| Extracellular Vesicles | 3 | 2021 | 46 | 0.340 |
Why?
|
| Pleural Neoplasms | 1 | 2010 | 18 | 0.340 |
Why?
|
| Epithelial Cells | 3 | 2021 | 392 | 0.290 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 349 | 0.270 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 506 | 0.260 |
Why?
|
| Sialic Acids | 4 | 2015 | 33 | 0.250 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 3 | 2013 | 12 | 0.240 |
Why?
|
| Host-Pathogen Interactions | 4 | 2019 | 262 | 0.240 |
Why?
|
| Virus Attachment | 2 | 2015 | 18 | 0.220 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 685 | 0.210 |
Why?
|
| BK Virus | 2 | 2014 | 23 | 0.210 |
Why?
|
| Polysaccharides | 2 | 2015 | 144 | 0.190 |
Why?
|
| Crotonates | 1 | 2021 | 4 | 0.180 |
Why?
|
| Toluidines | 1 | 2021 | 4 | 0.180 |
Why?
|
| Hydroxybutyrates | 1 | 2021 | 11 | 0.180 |
Why?
|
| DNA Viruses | 1 | 2021 | 17 | 0.180 |
Why?
|
| Nitriles | 1 | 2021 | 70 | 0.170 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2021 | 33 | 0.170 |
Why?
|
| Lentivirus | 1 | 2021 | 67 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 78 | 0.170 |
Why?
|
| Transfection | 5 | 2021 | 695 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 171 | 0.160 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 1 | 2019 | 2 | 0.150 |
Why?
|
| Humans | 26 | 2021 | 63545 | 0.150 |
Why?
|
| Ritanserin | 1 | 2018 | 2 | 0.140 |
Why?
|
| Meninges | 1 | 2018 | 10 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 297 | 0.140 |
Why?
|
| Dependovirus | 1 | 2024 | 709 | 0.140 |
Why?
|
| G(M1) Ganglioside | 1 | 2016 | 7 | 0.120 |
Why?
|
| Vacuoles | 1 | 2016 | 26 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2015 | 248 | 0.120 |
Why?
|
| Virus Assembly | 1 | 2015 | 53 | 0.110 |
Why?
|
| Virus Replication | 2 | 2014 | 321 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2015 | 176 | 0.110 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2013 | 1 | 0.100 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2013 | 7 | 0.100 |
Why?
|
| Thiophenes | 1 | 2013 | 29 | 0.100 |
Why?
|
| Benzamides | 1 | 2013 | 65 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2013 | 185 | 0.090 |
Why?
|
| HEK293 Cells | 3 | 2021 | 622 | 0.090 |
Why?
|
| Protein Conformation | 3 | 2015 | 780 | 0.090 |
Why?
|
| Autophagy | 1 | 2014 | 226 | 0.090 |
Why?
|
| Binding Sites | 3 | 2015 | 906 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2010 | 317 | 0.080 |
Why?
|
| Biopsy | 1 | 2010 | 447 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2004 | 35 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 527 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 979 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 769 | 0.070 |
Why?
|
| NFATC Transcription Factors | 1 | 2006 | 20 | 0.060 |
Why?
|
| Tumor Virus Infections | 1 | 2006 | 36 | 0.060 |
Why?
|
| Cyclosporine | 1 | 2006 | 77 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 674 | 0.060 |
Why?
|
| DNA, Viral | 2 | 2006 | 232 | 0.060 |
Why?
|
| Prognosis | 1 | 2010 | 1743 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2007 | 263 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2024 | 25 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 2020 | 99 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 294 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 251 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2024 | 230 | 0.050 |
Why?
|
| Mutant Proteins | 2 | 2015 | 105 | 0.050 |
Why?
|
| Crystallography, X-Ray | 2 | 2015 | 432 | 0.050 |
Why?
|
| Plasmids | 1 | 2004 | 292 | 0.050 |
Why?
|
| Virus Latency | 1 | 2003 | 32 | 0.050 |
Why?
|
| Cytokines | 1 | 2007 | 934 | 0.050 |
Why?
|
| Chlorpromazine | 1 | 2003 | 8 | 0.050 |
Why?
|
| Clozapine | 1 | 2003 | 32 | 0.050 |
Why?
|
| Animals | 5 | 2016 | 20715 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2004 | 477 | 0.050 |
Why?
|
| Demyelinating Diseases | 1 | 2021 | 15 | 0.040 |
Why?
|
| Astrocytes | 1 | 2021 | 119 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2004 | 628 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2021 | 105 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2021 | 120 | 0.040 |
Why?
|
| Phosphatidylinositols | 1 | 2020 | 52 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2004 | 1150 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2003 | 301 | 0.040 |
Why?
|
| Protein Binding | 1 | 2004 | 1603 | 0.040 |
Why?
|
| Serotonin | 2 | 2013 | 60 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 1664 | 0.040 |
Why?
|
| beta-Arrestins | 1 | 2019 | 4 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2015 | 664 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2014 | 536 | 0.040 |
Why?
|
| DNA Primers | 2 | 2010 | 292 | 0.040 |
Why?
|
| Time Factors | 1 | 2004 | 3708 | 0.030 |
Why?
|
| Luciferases | 2 | 2007 | 108 | 0.030 |
Why?
|
| Base Sequence | 2 | 2010 | 1331 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2015 | 61 | 0.030 |
Why?
|
| Glycolipids | 1 | 2015 | 44 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2021 | 881 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 2015 | 160 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 239 | 0.030 |
Why?
|
| Shiga Toxins | 1 | 2013 | 2 | 0.030 |
Why?
|
| Ricin | 1 | 2013 | 3 | 0.030 |
Why?
|
| Haplorhini | 1 | 2013 | 14 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 403 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2010 | 8 | 0.020 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2010 | 4 | 0.020 |
Why?
|
| Neuraminidase | 1 | 2010 | 42 | 0.020 |
Why?
|
| Glycosylation | 1 | 2010 | 137 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 490 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2007 | 48 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 258 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2006 | 133 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2006 | 146 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 154 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 612 | 0.010 |
Why?
|
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2004 | 2 | 0.010 |
Why?
|
| Dopamine Agonists | 1 | 2004 | 22 | 0.010 |
Why?
|
| Receptors, Dopamine | 1 | 2004 | 16 | 0.010 |
Why?
|
| Dopamine Antagonists | 1 | 2004 | 16 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 2004 | 32 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 236 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 676 | 0.010 |
Why?
|
| Endosomes | 1 | 2004 | 177 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 1590 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1993 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 142 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 467 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 10863 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 863 | 0.010 |
Why?
|